mgt615_course_announcement2 (2).png

Leadership in a Multi-disciplinary Organization

On February 22, 2020, Amarex President &CEO, Dr. Kazem Kazempour, will present a new course at Montgomery College, Rockville. Join us and explore key characteristics, traits and behaviors of effective leaders.

05 February 2020
IMAG1099_edited.jpg

2019 Regulatory Affairs Year in Review

2019 was an exciting year of growth and discovery for Amarex Clinical Research, and we are excited to report the below noteworthy achievements.

28 January 2020
Hana Makemmon lighter picture 07182017.p

Featured White Paper: Understanding Adaptive Designs for Clinical Trials

Amarex Clinical Research, LLC is pleased to announce that a white paper authored by Hana Mekonnen, MS, Senior Vice President of Biometrics for Amarex, was published in the NSF Health Sciences Journal, Issue 46.

24 January 2020
download.png

Follow-up: Amarex Keynotes at GLORIA NCKU | November 29, 2019, Tainan City, Taiwan

On 29 November 2019, at the Global Research & Industry Alliance of National Cheng-Kung University (GLORIA NCKU) in Tainan City, Taiwan, Dr. Kazem Kazempour, President & CEO of Amarex, keynoted on the topic of Current Regulatory Thinking on AI/ML as SaMDs.

19 December 2019

As a full-service, international CRO, Amarex Clinical Research has extensive experience successfully performing clinical studies across all phases of research and discovery, development, validation and approval.​​​

Recommended by the people who matter most: our clients.

 

Chief Medical Officer 

A Maryland Biotech Company

We have worked with Amarex on numerous projects and they consistently deliver high quality reliable service by leveraging a broad array of clinical and regulatory expertise. What sets them apart from other CROs is a creative entrepreneurial approach to drug development. They go beyond the technical aspects of clinical trial development and work with the sponsor to drive value and increase chances for success.

        

             5/5

Chief Technical Officer

A Canadian-based Infectious Diseases Organization

[Thank you to the team at Amarex] for the statistical support which proved to be invaluable and completely accurate in the final review by FDA. The cornerstone of this milestone achievement was the data from the clinical study, including the limit of detection study, and we came through [all FDA reviews with solid outcomes throughout]. From all of us here, a sincere thank you and well done to all at Amarex who worked on this project. We look forward to working with you again as we apply the successful platform to other diagnostic device developments in the future.

        

             5/5

AMAREX_NSF_1C.png
  • Facebook Social Icon
  • Twitter Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon

           

           © 2019 Amarex Clinical Research, LLC. All rights reserved.                                                                                                                                                                                                                                                   Top of Page 

Contact     Privacy Policy     Clinical Site Registration     WebView

NSF Mark_100x100.jpg